Liver disease and erythropoietic protoporphyria: A concise review

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

534

HTML

5227

Figures (1-1)

160

Tables (1-1)

155

Sum=6076

Sep 28, 2010 (publication date) through May 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Sep 28, 2010; 16(36): 4526-4531
Published online Sep 28, 2010. doi: 10.3748/wjg.v16.i36.4526

Table 1 Pathogenic mechanisms and therapeutic approaches of erythropoietic protoporphyria

Pathogenic mechanism	Treatment
Induce bile flow	Ursodeoxycholic acid
Reduce protoporphyrin production	Parenteral iron
	Transfusion of erythrocytes
	Infusions of hematin
Reduce protoporphyrin levels	Plasmapheresis
Reduce protoporphyrin levels	Extracorporeal albumin dialysis
Interrupt enterohepatic circulation	Cholestyramine
Interrupt enterohepatic circulation	Activated charcoal
Protect hepatocytes from toxic damage	N-acetyl cysteine
Remove the principal source of protoporphyrin	Bone marrow transplant
Erythropoietic protoporphyria-related liver failure	Liver transplant

Citation: Casanova-González MJ, Trapero-Marugán M, Jones EA, Moreno-Otero R. Liver disease and erythropoietic protoporphyria: A concise review. World J Gastroenterol 2010; 16(36): 4526-4531
URL: https://www.wjgnet.com/1007-9327/full/v16/i36/4526.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i36.4526